SPRINT-TB Releases Its 2016/2017 Annual Report
SPRINT-TB has published its Annual Report for 2016/2017 — the first in what is planned as a yearly series that keeps the scientific community and the wider public up to date on the programme's work, progress and research breakthroughs. The SPRINT-TB programme officially launched in July 2014, and in little more than a year it had already produced a broad range of findings and achievements.
Among the highlights of the programme's first year is Theme 1's finding that bortezomib is highly active against a novel M. tuberculosis target. In Theme 2, researchers have started investigating bortezomib derivatives that may kill bacteria more selectively while reducing toxicity.
Theme 3 has established a platform for testing new drugs and drug combinations in humans — the whole blood bactericidal activity assay — and adapted it to evaluate both antibacterial drugs and compounds that modulate the host immune response. Theme 4 has begun a TB health services research collaboration with Cambodia's national TB programme and opened the SPRINT-TB office in Phnom Penh.
The SPRINT-TB Annual Report 2016/2017 is available to download from the annual report page.
Download the Annual ReportOur Research Themes
Discover SPRINT-TB
Browse News Archives
- September 2018
- December 2017
- March 2017
- December 2016
- September 2016
- March 2016
- February 2016
- December 2015
- November 2015
- October 2015
- September 2015
- July 2015
- May 2015
- April 2015
- March 2015
- February 2015
- November 2014
- October 2014
- September 2014
- July 2014
Categories: All · This article · Comments
This archive page gathers SPRINT-TB news from March 2017, centred on the release of the 2016/2017 Annual Report. Use the links above to jump to individual research themes, download the report, or browse other months in the news archive.